The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...

President Donald Trump's tax cut and spending bill faces a critical stress test on Wednesday as Republicans in the U.S. House ...